LP
ENZN

LMR Partners’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

LMR Partners’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-11,250
Closed -$13K – 523
2014
Q3 		$13K Sell
11,250
-101,251
-90% -$125K ﹤0.01% 316
2014
Q2 		$117K Buy
+112,501
New +$107K 0.01% 430

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LMR Partners's ENZN Position: Q4 2014 in Review

LMR Partners sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q4 2014, closing a stake of 11,250 shares — an estimated $13K sold.

LMR Partners first reported a position in ENZN in Q2 2014 and held it in 2 quarters. The position peaked at $117K in Q2 2014. 57 funds tracked by Wall St. Rank hold ENZN as of Q4 2014.

  • LMR Partners reported no remaining ENZON PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • LMR Partners sold 11,250 ENZON PHARMACEUTICALS INC shares in Q4 2014, an estimated $13K.
  • LMR Partners first reported a position in ENZON PHARMACEUTICALS INC in Q2 2014 and held it in 2 quarters.
  • LMR Partners's ENZON PHARMACEUTICALS INC position peaked at $117K in Q2 2014.
  • 57 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q4 2014.

Based on LMR Partners's 13F filing for Q4 2014, filed 20 Jan 2015.